Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Martin Cannon

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Cannon, Martin

Item TypeName
Academic Article Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer.
Academic Article Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Academic Article Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Academic Article Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Academic Article Immunological treatment of ovarian cancer.
Academic Article Cellular immunotherapy for ovarian cancer.
Academic Article rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.
Academic Article Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage?
Academic Article Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.
Academic Article Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen.
Academic Article Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.
Academic Article Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Academic Article Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer.
Academic Article Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Academic Article Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.
Academic Article Overexpression of HER-2/neu in uterine serous papillary cancer.
Academic Article Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment?
Concept Ovarian Neoplasms
Academic Article Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenase.
Academic Article Novel target antigens for dendritic cell immunotheraphy of ovarian cancer
Academic Article Induction of specific cytotoxic T cells by dendritic cells primed with acid-eluted autologous peptides in patients with ovarian cancer
Academic Article Dendritic cell vaccination agains ovarian cancer-tipping the Treg/Th17 balance to therapeutic advantage?
Academic Article Increased levels of interleukin-10 and transforming growth factor-B in the plasmam and ascitic fluid of patients with advanced ovarian cancer
Academic Article Sperm protein 17 vaccination induces a long-term protective immune response against ovarian cancer
Academic Article Effective prevention and therapy of ovarian cancer with sperm protein 17 vaccination
Academic Article Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotheraphy for ovarian cancer
Academic Article Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and theraphy
Academic Article Induction of tumor-specific CD8+ cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells in patients with advanced ovarian cancer
Academic Article Treatment of chemotheraphy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin (CPE)
Academic Article Dendritic cell redirection of regulatory T cell responses to ovarian cancer antigens
Academic Article Cellular immunotherapy and immune regulation in ovarian cancer
Academic Article Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen A2-positive healthy donors and patients with advanced ovarian cancer
Academic Article Induction of tumor-specific CD8+ lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells in patients with advanced ovarian cancer
Academic Article Induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells in patients with advanced ovarian cancer
Academic Article Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin (CPE)
Academic Article Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer.
Academic Article Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer.
Academic Article The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer.
Academic Article Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In?Vitro and in a Syngeneic Murine Dissemination Model.
Academic Article IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.
Academic Article Further clinical advancement of dendritic cell vaccination against ovarian cancer.
Grant Dendritic cell immunotherapy for ovarian cancer
Grant Novel target antigens for ovarian cancer immunotherapy
Grant CD 8+ Cytotoxic T Cell Responses to Novel Ovarian Cancer Antigens (immunotherapy, ovarian cancer, gynecologic oncology, cytotoxic T lymphocytes, dendr
Grant Dendritic cell vaccination and immune regulation in ovarian cancer
Grant Dendritic cell activation of therapeutic Th17 responses against ovarian cancer
Grant Th17-inducing vaccine strategies for preventing progression of ovarian cancer
Grant Mayo Clinic Ovarian Cancer SPORE - Pilot Project
Grant Mayo Clinic Ovarian Cancer SPORE - Pilot Project
Grant Enhancement of Th17-Inducing DC Vaccination for Ovarian Cancer Through PARPi-Mediated Activation of Innate Immunity in the Tumor Microenvironment
Academic Article Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
Grant Dendritic cell activation of therapeutic Th17 responses against ovarian cancer
Academic Article Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade.
Grant Proteogenomic analysis of responders versus nonresponders in a Phase I clinical trial of Th17-inducing dendritic cell vaccination for advanced stage ovarian cancer
Grant Understanding and targeting myeloid populations in ovarian cancer for enhancing therapeutic effects
Grant Mechanisms of Th17-DC immunotherapy for ovarian cancer

Search Criteria
  • Ovarian Neoplasms